Credit: Christoph Burgstedt/Getty Images When asked why he founded Unnatural Products (UNP), a developer of oral macrocyclic peptide therapeutics, Cameron Pye, PhD, attributes the decision at least in part to “being in the right place at the right time …

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, including a first-of-its-kind molecule in blood cancer. Wednesday, Chinese regulators announced (Chinese) the conditional approval …

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Be sure to come back regularly …

The U.S. Food and Drug Administration (FDA) has accepted and granted priority review for Merck & Co. Inc.’s MRK new supplemental Biologics License Application (sBLA) seeking approval to update the U.S. product label based on the Phase 3 ZENITH trial …

As of 1505 BST, the Dow Jones Industrial Average was down 0.21% at 44,402.27, while the S&P 500 advanced 0.03% to 6,199.60 and the Nasdaq Composite came out of the gate 0.29% firmer at 20,261.80. The Dow opened 92.67 points lower on Wednesday, taking a …

… Medinova Meitheal Pharmaceuticals Menarini MenoGeniX Merck and Co Merck KGaA Microbix Biosystems MicroGenDX …

… companies such as Pfizer Inc., Merck And Co. Inc., Sanofi S.A., Eli …

… Intellia Therapeutics Janssen Biotech Lundbeck Merck and Co Mitsubishi Tanabe Pharma Moderna Novartis …

… & Johnson Amgen Roche Sanofi Merck and Co Novartis GlaxoSmithKline AstraZeneca Gilead Sciences …

New York, USA, July 02, 2025 (GLOBE NEWSWIRE) -- Global Real-World Evidence Solution Market to Grow at a Substantial Growth Rate of ~8% by 2032 | DelveInsight The real-world evidence solutions market is largely driven by the increasing prevalence of …